Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Observational 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Carcinoma, Renal Cell 77Kidney Neoplasms 23Prostatic Neoplasms 22Neoplasm Metastasis 13Colorectal Neoplasms 10Neoplasms 8Melanoma 7Carcinoma, Transitional Cell 6Breast Neoplasms 6Urinary Bladder Neoplasms 5Stomach Neoplasms 5Glioblastoma 5Carcinoma, Non-Small-Cell Lung 5Pancreatic Neoplasms 4Ovarian Neoplasms 4Carcinoma, Hepatocellular 4Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Sarcoma 3Urologic Neoplasms 2Triple Negative Breast Neoplasms 2Myeloproliferative Disorders 2Multiple Myeloma 2Hereditary leiomyomatosis and renal cell cancer 2Hematologic Neoplasms 2Financial Stress 2Esophageal Neoplasms 2Endometrial Neoplasms 2Colonic Neoplasms 2Cholangiocarcinoma 2

Interventions

pazopanib 2Sunitinib 2Sorafenib 2Bevacizumab 2Surveys and Questionnaires 1Quality Indicators, Health Care 1Immunization, Secondary 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Financial Stress × Bevacizumab × Genitourinary × Clear all
NCT01381601 2013-05-13

Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (Pharmetrics)

GlaxoSmithKline

Completed
1 enrolled
Genitourinary

Financial Stress, Carcinoma, Renal Cell

NCT01381614 2013-05-13

Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (IHCIS)

GlaxoSmithKline

Completed
1 enrolled
Genitourinary

Financial Stress, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡